Hong Kong-listed CXO concept stocks surged at the opening, with WuXi AppTec rising more than 10%.

The concept stocks of CXO in Hong Kong stock market surged in the early trading session, with Wuxi AppTec rising more than 10%, followed by Ascletis Pharma, Kangmei Pharmaceutical, Zai Lab, and Wuxi Biologics.